Peptidomics Analysis of Transient Regeneration in the Neonatal Mouse Heart. Issue 9 (18th May 2017)

• Record Type: Journal Article
• Authors: Fan, Yi; Zhang, Qijun; Li, Hua; Cheng, Zijie; Li, Xing; Chen, Yumei; Shen, Yahui; Wang, Liansheng; Song, Guixian; Qian, Lingmei
• Is Part Of: Journal of cellular biochemistry. Volume 118:Issue 9(2017)
• Page Start: 2828
• Page End: 2840
• Publication Date: 2017-05-18
• Subjects: HEART REGENERATION -- NEONATAL MOUSE -- PEPTIDOMICS -- MASS SPECTROMETRY; Cytochemistry -- Periodicals; 572
• DOI: 10.1002/jcb.25933
• Languages: English
• ISSNs: 0730-2312

Abstract

ABSTRACT: Neonatal mouse hearts have completely regenerative capability after birth, but the ability to regenerate rapidly lost after 7 days, the mechanism has not been clarified. Previous studies have shown that mRNA profile of adult mouse changed greatly compared to neonatal mouse. So far, there is no research of peptidomics related to heart regeneration. In order to explore the changes of proteins, enzymes, and peptides related to the transient regeneration, we used comparative petidomics technique to compare the endogenous peptides in the mouse heart of postnatal 1 and 7 days. In final, we identified 236 differentially expressed peptides, 169 of which were upregulated and 67 were downregulated in the postnatal 1 day heart, and also predicted 36 functional peptides associated with transient regeneration. The predicted 36 candidate peptides are located in the important domains of precursor proteins and/or contain the post‐transcriptional modification (PTM) sites, which are involved in the biological processes of cardiac development, cardiac muscle disease, cell proliferation, necrosis, and apoptosis. In conclusion, for the first time, we compared the peptidomics profiles of neonatal heart between postnatal 1 day and postnatal 7 day. This study provides a new direction and an important basis for the mechanism research of transient regeneration in neonatal heart. J. Cell. Biochem. 118: 2828–2840, 2017. © 2017 Wiley Periodicals, Inc.